defactinib   Click here for help

GtoPdb Ligand ID: 7910

Synonyms: PF-04554878 | VS-6063
PDB Ligand
Compound class: Synthetic organic
Comment: Defactinib (VS-6063) is an orally bioavailable, second generation, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities [1,9]. Phase 1 clinical trial results show that Defactinib is well tolerated and exhibits some clinical efficacy in patients (albeit in only two reported subjects) with advanced solid tumours [3,11].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 150.48
Molecular weight 510.14
XLogP 2.2
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)c1ccc(cc1)Nc1ncc(c(n1)NCc1nccnc1N(S(=O)(=O)C)C)C(F)(F)F
Isomeric SMILES CNC(=O)c1ccc(cc1)Nc1ncc(c(n1)NCc1nccnc1N(S(=O)(=O)C)C)C(F)(F)F
InChI InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)
InChI Key FWLMVFUGMHIOAA-UHFFFAOYSA-N
Bioactivity Comments
Phosphorylation of FAK at Tyr397 is time and dose-dependently inhibited in response to defactinib treatment [4], and defactinib in combination with paclitaxel, inhibits tumour cell proliferation in vitro and in vivo. Defactinib is a weak inhibitor of CYP3A, so is expected to be more effective in combination with docetaxel than the first generation FAK inhibitor PF-562271 (which is a potent CYP3A inhibitor, so may cause toxicity in combination with docetaxel) [6].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
large tumor suppressor kinase 1 Hs Inhibitor Inhibition 5.0 pKd - 5
pKd 5.0 (Kd 9.12x10-6 M) [5]